Home » Newsletters » BioWorld Science

BioWorld Science

May 30, 2014

View Archived Issues

Muscle homing peptide-PMO conjugate shows promise in dystrophin-deficient mice

Novel bispecific anti-VEGF/ANG-2 MAb for the treatment of ocular disorders

Vitamin D supplementation tested for prediabetes progression treatment

Extended-spectrum pleuromutilins tested for efficacy against antimicrobial-resistant infections

Clinical evaluation of a dendritic cell-targeting vaccine for the treatment of refractory tumors

Investigators develop and characterize protein kinase C interaction disruptors

Nonhuman primate efficacy and human safety assessed for agent against Marburg virus

Bristol-Myers Squibb patents novel NS3/NS4A inhibitors for HCV

Novel multipeptide cocktail compositions reported by Dana-Farber Cancer Institute

Bayer Schering Pharma patents novel sGC activators

Researchers at Medeia Therapeutics synthesize novel agents for neurodegenerative disorders

Single-chain insulin analogues disclosed by Case Western Reserve University

Small-molecule Abeta oligomer receptor antagonist reported for Alzheimer's disease

Xencor begins phase Ia study of XmAb-7195 for asthma

Lilly presents novel MOGAT2 inhibitors for hypertriglyceridemia

PolyTherics and Alpha Cancer Technologies establish collaboration

Trimel reports topline phase II results for Tefina

UCB Celltech initiates phase I trial in patients with psoriatic arthritis

FDA accepts for filing Rockwell's NDA for iron replacement therapy

Reata and AbbVie to initiate phase II trial of lotion to prevent radiation dermatitis

Transgene discloses phase IIb data for TG-4010

Tekmira to initiate phase I/II trial of RNAi agent in hepatocellular carcinoma

Dosing under way in phase IIa study of LPCN-1111 in hypogonadal men

OncoCyte and Cornell University collaborate to develop lung cancer diagnostic

Partners in Parkinson's initiative launched by the Michael J. Fox Foundation and AbbVie

Micromedic to develop diagnostic for risk of bisphosphonate-related osteonecrosis of the jaw

Sorafenib gains E.U. approval for thyroid cancer

NDA submission for safinamide for Parkinson's disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...